Conducting Pre Operative Evaluations

Documents to Request

• Surgeon's procedure description with estimated blood loss and duration
• Anesthesia questionnaire if completed
• Recent cardiac testing (ECG, echocardiogram, stress test) if available
• Pulmonary function tests if known pulmonary disease
• Sleep study results if diagnosed OSA
• Current medication list with anticoagulant/antiplatelet details
• Recent labs: CBC, BMP, coagulation studies, A1c if diabetic, LFTs if hepatic concern
• Operative reports from prior surgeries noting anesthetic complications
• Advance directive documentation

Step 1: Surgical Risk Stratification

Classify the procedure per ACC/AHA categories:

For low-risk surgery: proceed without further cardiac testing regardless of patient factors (ACC/AHA Class III recommendation—testing not indicated).

Step 2: Cardiac Risk Assessment (ACC/AHA Stepwise Algorithm)

Step 2a: Is there an acute coronary syndrome or decompensated HF?

• If yes: defer elective surgery; cardiology consultation; manage acute condition first

Step 2b: Estimate surgical risk (Step 1 above)

• Low risk → proceed to surgery without cardiac testing

Step 2c: Assess functional capacity

• ≥4 METs (can climb a flight of stairs, walk 2 blocks on level ground, do heavy housework) → proceed without testing
• <4 METs or unable to assess → proceed to Step 2d

Step 2d: Calculate RCRI (Revised Cardiac Risk Index / Lee Index)

Do NOT order stress testing if the result will not change surgical decision.

Step 3: Pulmonary Risk Assessment

Assess risk using ARISCAT score or clinical judgment:

Do NOT order routine preoperative PFTs unless:

• Unexplained dyspnea not adequately characterized
• Known lung disease requiring optimization before thoracic or upper abdominal surgery
• Lung resection planned (need to estimate post-resection pulmonary function)

Step 4: Perioperative Medication Management

Step 5: Pre-Operative Assessment Letter

Structure the communication to the surgeon:

1. Medical conditions relevant to surgical risk — list with severity and current management
2. Cardiac risk assessment — RCRI score, functional capacity, need for further testing
3. Pulmonary risk — COPD/OSA status, CPAP requirements, PFT results if obtained
4. Medication management — specific hold/continue instructions with dates
5. Laboratory requirements — any pending labs needed before surgery date
6. Optimization recommendations — items to address before surgery (e.g., smoking cessation, A1c optimization, anemia correction)
7. Risk statement — "The patient is at [low/moderate/elevated] perioperative risk based on RCRI and procedure classification. Risk-benefit discussion has been completed."

Do NOT write "cleared for surgery"—this implies a guarantee that no complication will occur and is medically and legally indefensible.

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Is the surgical procedure classified by risk category (low vs. elevated)?
2. Has functional capacity been assessed in METs?
3. Is the RCRI calculated with appropriate cardiac testing recommendation?
4. Are all medication hold/continue instructions specific with timing?
5. Does the assessment letter communicate risk clearly without using the word "cleared"?

Quality Audit

• Surgical procedure identified with risk category (low vs. elevated)
• Urgency documented (elective, urgent, emergent)
• Functional capacity assessed in METs with method documented
• RCRI calculated with all six factors addressed
• Cardiac testing ordered only when results would change management
• Pulmonary risk assessed with OSA, COPD, smoking status documented
• Medication management table completed with specific hold/continue dates
• Anticoagulation bridging decision documented with rationale
• Diabetic medication adjustment plan specified for NPO period
• Labs ordered as appropriate for procedure and comorbidities (not reflexive panels)
• Assessment letter structured without the phrase "cleared for surgery"
• Advance directive status documented or discussion offered
• Patient informed of perioperative risks relevant to their medical conditions
• Follow-up plan established for post-surgical medication resumption

Guidelines

• Never order routine pre-operative testing (ECG, CXR, labs) for low-risk surgery in healthy patients—Choosing Wisely recommendation against routine preoperative testing
• Beta-blockers should never be initiated de novo on the day of surgery; the POISE trial showed increased stroke and mortality with perioperative beta-blocker initiation
• "Medical clearance" is not a medical term; the role of the primary care clinician is risk assessment and optimization, not guaranteeing surgical safety
• Asymptomatic carotid bruit does not require preoperative carotid imaging unless the patient has neurologic symptoms
• Pre-operative ECG is reasonable for patients with known cardiac disease, significant risk factors, or elevated-risk surgery, but is NOT indicated for low-risk surgery
• Post-menopausal bleeding, new murmur, or unexplained syncope discovered during preoperative evaluation require diagnostic workup before elective surgery proceeds
• Patients with drug-eluting stents within 6 months require cardiology consultation before stopping dual antiplatelet therapy
• Communicate the assessment to the surgeon, anesthesiologist, and patient—not just the chart